151 related articles for article (PubMed ID: 21087322)
1. Response of experimental malignant melanoma models to the pan-Aurora kinase inhibitor VE-465.
Pirker C; Lötsch D; Spiegl-Kreinecker S; Jantscher F; Sutterlüty H; Micksche M; Grusch M; Berger W
Exp Dermatol; 2010 Dec; 19(12):1040-7. PubMed ID: 21087322
[TBL] [Abstract][Full Text] [Related]
2. The induction of polyploidy or apoptosis by the Aurora A kinase inhibitor MK8745 is p53-dependent.
Nair JS; Ho AL; Schwartz GK
Cell Cycle; 2012 Feb; 11(4):807-17. PubMed ID: 22293494
[TBL] [Abstract][Full Text] [Related]
3. Aurora kinase inhibitor VE 465 synergistically enhances cytotoxicity of carboplatin in ovarian cancer cells through induction of apoptosis and downregulation of histone 3.
Fu S; Li Y; Huang J; Liu T; Hong Z; Chen A; Bast RC; Kavanagh JJ; Gershenson DM; Sood AK; Hu W
Cancer Biol Ther; 2012 Sep; 13(11):1034-41. PubMed ID: 22895067
[TBL] [Abstract][Full Text] [Related]
4. The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function.
Gizatullin F; Yao Y; Kung V; Harding MW; Loda M; Shapiro GI
Cancer Res; 2006 Aug; 66(15):7668-77. PubMed ID: 16885368
[TBL] [Abstract][Full Text] [Related]
5. Combination of nutlin-3 and VX-680 selectively targets p53 mutant cells with reversible effects on cells expressing wild-type p53.
Cheok CF; Kua N; Kaldis P; Lane DP
Cell Death Differ; 2010 Sep; 17(9):1486-500. PubMed ID: 20203688
[TBL] [Abstract][Full Text] [Related]
6. Determinants for the efficiency of anticancer drugs targeting either Aurora-A or Aurora-B kinases in human colon carcinoma cells.
Kaestner P; Stolz A; Bastians H
Mol Cancer Ther; 2009 Jul; 8(7):2046-56. PubMed ID: 19584233
[TBL] [Abstract][Full Text] [Related]
7. Concomitant inhibition of Mdm2-p53 interaction and Aurora kinases activates the p53-dependent postmitotic checkpoints and synergistically induces p53-mediated mitochondrial apoptosis along with reduced endoreduplication in acute myelogenous leukemia.
Kojima K; Konopleva M; Tsao T; Nakakuma H; Andreeff M
Blood; 2008 Oct; 112(7):2886-95. PubMed ID: 18633130
[TBL] [Abstract][Full Text] [Related]
8. Short and long-term tumor cell responses to Aurora kinase inhibitors.
Dreier MR; Grabovich AZ; Katusin JD; Taylor WR
Exp Cell Res; 2009 Apr; 315(7):1085-99. PubMed ID: 19233169
[TBL] [Abstract][Full Text] [Related]
9. Vincristine potentiates the anti-proliferative effect of an aurora kinase inhibitor, VE-465, in myeloid leukemia cells.
Yoshida K; Nagai T; Ohmine K; Uesawa M; Sripayap P; Ishida Y; Ozawa K
Biochem Pharmacol; 2011 Dec; 82(12):1884-90. PubMed ID: 21971583
[TBL] [Abstract][Full Text] [Related]
10. Co-treatment with vorinostat synergistically enhances activity of Aurora kinase inhibitor against human breast cancer cells.
Fiskus W; Hembruff SL; Rao R; Sharma P; Balusu R; Venkannagari S; Smith JE; Peth K; Peiper SC; Bhalla KN
Breast Cancer Res Treat; 2012 Sep; 135(2):433-44. PubMed ID: 22825030
[TBL] [Abstract][Full Text] [Related]
11. AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo.
Yang J; Ikezoe T; Nishioka C; Tasaka T; Taniguchi A; Kuwayama Y; Komatsu N; Bandobashi K; Togitani K; Koeffler HP; Taguchi H; Yokoyama A
Blood; 2007 Sep; 110(6):2034-40. PubMed ID: 17495131
[TBL] [Abstract][Full Text] [Related]
12. Cucurbitacin-I inhibits Aurora kinase A, Aurora kinase B and survivin, induces defects in cell cycle progression and promotes ABT-737-induced cell death in a caspase-independent manner in malignant human glioma cells.
Premkumar DR; Jane EP; Pollack IF
Cancer Biol Ther; 2015; 16(2):233-43. PubMed ID: 25482928
[TBL] [Abstract][Full Text] [Related]
13. The Aurora kinases inhibitor VE-465 is a novel treatment for glioblastoma multiforme.
Lee PY; Chen CL; Lin ZZ; Cheng AL; Chen EI; Whang-Peng J; Huang CY
Oncology; 2013; 84(6):326-35. PubMed ID: 23636005
[TBL] [Abstract][Full Text] [Related]
14. Integrity of p53 associated pathways determines induction of apoptosis of tumor cells resistant to Aurora-A kinase inhibitors.
Shionome Y; Yan L; Liu S; Saeki T; Ouchi T
PLoS One; 2013; 8(1):e55457. PubMed ID: 23383195
[TBL] [Abstract][Full Text] [Related]
15. The aurora kinase inhibitor CCT137690 downregulates MYCN and sensitizes MYCN-amplified neuroblastoma in vivo.
Faisal A; Vaughan L; Bavetsias V; Sun C; Atrash B; Avery S; Jamin Y; Robinson SP; Workman P; Blagg J; Raynaud FI; Eccles SA; Chesler L; Linardopoulos S
Mol Cancer Ther; 2011 Nov; 10(11):2115-23. PubMed ID: 21885865
[TBL] [Abstract][Full Text] [Related]
16. Aurora B kinase inhibition in mitosis: strategies for optimising the use of aurora kinase inhibitors such as AT9283.
Curry J; Angove H; Fazal L; Lyons J; Reule M; Thompson N; Wallis N
Cell Cycle; 2009 Jun; 8(12):1921-9. PubMed ID: 19440047
[TBL] [Abstract][Full Text] [Related]
17. Aurora A kinase RNAi and small molecule inhibition of Aurora kinases with VE-465 induce apoptotic death in multiple myeloma cells.
Evans R; Naber C; Steffler T; Checkland T; Keats J; Maxwell C; Perry T; Chau H; Belch A; Pilarski L; Reiman T
Leuk Lymphoma; 2008 Mar; 49(3):559-69. PubMed ID: 18297535
[TBL] [Abstract][Full Text] [Related]
18. Aurora B kinase regulates the postmitotic endoreduplication checkpoint via phosphorylation of the retinoblastoma protein at serine 780.
Nair JS; Ho AL; Tse AN; Coward J; Cheema H; Ambrosini G; Keen N; Schwartz GK
Mol Biol Cell; 2009 Apr; 20(8):2218-28. PubMed ID: 19225156
[TBL] [Abstract][Full Text] [Related]
19. Aurora kinase inhibitor AZD1152 negatively affects the growth and survival of HTLV-1-infected T lymphocytes in vitro.
Tomita M; Tanaka Y; Mori N
Int J Cancer; 2010 Oct; 127(7):1584-94. PubMed ID: 20091867
[TBL] [Abstract][Full Text] [Related]
20. Identification of aurora kinase B and Wee1-like protein kinase as downstream targets of (V600E)B-RAF in melanoma.
Sharma A; Madhunapantula SV; Gowda R; Berg A; Neves RI; Robertson GP
Am J Pathol; 2013 Apr; 182(4):1151-62. PubMed ID: 23416158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
